RELCHEMQ.NSRELCHEMQ.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.88% | -19.63% | -0.22% | +8.65% | -11.16% |
| Gross Profit Growth | +197.86% | +30.30% | +133.28% | -3.97% | -21.31% |
| EBITDA Growth | +13.96% | +839.50% | +11.68% | +8.05% | +16.52% |
| Operating Income Growth | +11.84% | +38.73% | +195.98% | +151.67% | +28.17% |
| Net Income Growth | +215.52% | +300.22% | +80.96% | +16.04% | +314.03% |
| EPS Growth | +220.59% | +300.00% | +80.77% | +15.87% | +307.69% |
| EPS Diluted Growth | +220.59% | +300.00% | +80.77% | +15.87% | +307.69% |
| Weighted Average Shares Growth | -1.55% | -1.49% | +0.10% | +0.15% | +1.56% |
| Weighted Average Shares Diluted Growth | -1.55% | -1.49% | +0.10% | +0.15% | +1.56% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +185.54% | +0.00% | +55.09% | +0.00% |
| Inventory Growth | +0.00% | +28.42% | +0.00% | +21.74% | +0.00% |
| Asset Growth | +0.00% | -1.39% | +0.00% | +0.81% | +0.00% |
| Book Value per Share Growth | +3.28% | +4.27% | +2.61% | +3.35% | +0.00% |
| Debt Growth | +0.00% | -6.48% | +0.00% | -5.51% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | +27.70% | -100.00% | +0.00% | +0.00% |